"Palladium" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A chemical element having an atomic weight of 106.4, atomic number of 46, and the symbol Pd. It is a white, ductile metal resembling platinum, and following it in abundance and importance of applications. It is used in dentistry in the form of gold, silver, and copper alloys.
Descriptor ID |
D010165
|
MeSH Number(s) |
D01.268.556.680 D01.268.956.718 D01.552.544.680
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Palladium".
Below are MeSH descriptors whose meaning is more specific than "Palladium".
This graph shows the total number of publications written about "Palladium" by people in this website by year, and whether "Palladium" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 1 | 0 | 1 |
1999 | 1 | 0 | 1 |
2000 | 1 | 1 | 2 |
2001 | 0 | 1 | 1 |
2003 | 1 | 2 | 3 |
2004 | 0 | 2 | 2 |
2005 | 1 | 1 | 2 |
2006 | 0 | 1 | 1 |
2008 | 2 | 0 | 2 |
2009 | 2 | 0 | 2 |
2011 | 3 | 2 | 5 |
2012 | 3 | 0 | 3 |
2013 | 1 | 1 | 2 |
2014 | 1 | 0 | 1 |
2015 | 0 | 1 | 1 |
2017 | 1 | 1 | 2 |
2018 | 0 | 1 | 1 |
2019 | 0 | 2 | 2 |
2020 | 0 | 2 | 2 |
2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Palladium" by people in Profiles.
-
Outcomes after PD-103 versus I-125 for low dose rate prostate brachytherapy monotherapy: An international, multi-institutional study. Radiother Oncol. 2023 06; 183:109599.
-
Predictors of urinary toxicity with MRI-assisted radiosurgery for low-dose-rate prostate brachytherapy. Brachytherapy. 2020 Sep - Oct; 19(5):574-583.
-
C-N Coupling of DNA-Conjugated (Hetero)aryl Bromides and Chlorides for DNA-Encoded Chemical Library Synthesis. Bioconjug Chem. 2020 03 18; 31(3):770-780.
-
MRI-assisted radiosurgery: A quality assurance nomogram for palladium-103 and iodine-125 prostate brachytherapy. Brachytherapy. 2020 Jan - Feb; 19(1):38-42.
-
Palladium-Catalyzed Hydroxycarbonylation of (Hetero)aryl Halides for DNA-Encoded Chemical Library Synthesis. Bioconjug Chem. 2019 08 21; 30(8):2209-2215.
-
Metallic Nanoislands on Graphene for Monitoring Swallowing Activity in Head and Neck Cancer Patients. ACS Nano. 2018 06 26; 12(6):5913-5922.
-
Synthesis of Unsymmetrical 2,6-Diarylanilines by Palladium-Catalyzed C-H Bond Functionalization Methodology. J Org Chem. 2018 05 18; 83(10):5844-5850.
-
Patient-reported health-related quality of life for men treated with low-dose-rate prostate brachytherapy as monotherapy with 125-iodine, 103-palladium, or 131-cesium: Results of a prospective phase II study. Brachytherapy. 2018 Mar - Apr; 17(2):265-276.
-
The American College of Radiology and the American Brachytherapy Society practice parameter for the performance of low-dose-rate brachytherapy. Brachytherapy. 2017 Jan - Feb; 16(1):68-74.
-
Synthetic studies of 7-oxygenated aporphine alkaloids: preparation of (-)-oliveroline, (-)-nornuciferidine, and derivatives. Org Lett. 2015 Mar 06; 17(5):1134-7.